Virtual Medicinal Product (VMP)
-
Hydroxyapatite 830mg tablets
Name Details
Current Name
Hydroxyapatite 830mg tablets
|
Start Date
15-12-2002
|
End Date
|
Unit Dose & Form Information
- DF Indicator
- Discrete
- UDFS Indicator
- 1.0
- UDFS UOM
- tablet
- Unit Dose UOM
- tablet
Summary
- Prescribing Status
- Valid as a prescribable product
- Controlled Drug Category
- No Controlled Drug Status
- Route
- Oral
- Form
- Oral tablet
- Ontology Form/Route
- tablet.oral
- Non-availability Indicator
- Actual Products not Available
- Name Basis
- BAN - British Approved Name
Codes
- ATC Code
-
n/a
SNOMED Codes
Code
|
Start Date
|
End Date
|
42013211000001101 |
03-07-2023 |
|
329165006 |
15-12-2002 |
02-07-2023 |
VMP Ingredients
VMP ingredients table
Hydroxyapatite |
Based on Ingredient Substance |
|
830 mg |
|
Name
Hydroxyapatite
Basis of strength description
Based on Ingredient Substance
BOSS
Strength and UOM (Nmr)
830.0
Strength and UOM (Dmr)
Virtual Medicinal Product Pack (VMPP) Information